MD-2 Gene Variant rs1809441: Understanding Allergy Associations
The rs1809441 variant is a single nucleotide polymorphism located in the promoter region of the MD-2 gene. Research has investigated its statistical association with levels of Der p 2-specific IgE and the prevalence of certain allergic symptoms.
What each genotype means
Typical MD-2 expression
This genotype is considered the reference or common form in many populations. Research suggests individuals with this genotype may have lower levels of Der p 2-specific IgE compared to those carrying the T allele.
Carried by approximately 28% of the population based on 1000 Genomes data for this variant.
Intermediate allergic risk profile
This heterozygous genotype is associated with an intermediate level of MD-2 promoter activity. Studies indicate that carriers may show moderate levels of Der p 2-specific IgE and immune response markers compared to homozygous individuals.
Carried by approximately 50% of the population based on 1000 Genomes data for this variant.
Increased allergic sensitivity
This genotype has been observed more frequently in individuals with Der p 2-sensitive allergies. Research suggests it may lead to increased expression of MD-2 and proinflammatory cytokines, potentially enhancing allergic inflammation; however, these findings are primarily based on specific study cohorts and may not apply to all ancestries.
Carried by approximately 22% of the population based on 1000 Genomes data for this variant.
What is rs1809441?
The rs1809441 variant is a specific genetic change, or single nucleotide polymorphism (SNP), located within the promoter region of the LY96 gene, which encodes the MD-2 protein. A promoter region is a segment of DNA that acts as a control switch, determining how much of a specific protein is produced by the cell. Because this variant sits in a regulatory area, researchers have hypothesized that it might influence the expression levels of MD-2. In genetic databases, this variant is tracked by its rsID, a unique identifier used by scientists to catalog variations across the human genome. While it is a well-documented site of variation, it is important to note that the presence of this SNP does not inherently cause a disease; rather, it is a marker that researchers study to understand how genetic differences might correlate with biological traits or immune responses in different populations.
The Role of the MD-2 Gene
The LY96 gene provides instructions for creating the MD-2 protein, which is a critical component of the innate immune system. MD-2 functions as a co-receptor that associates with Toll-like receptor 4 (TLR4) on the surface of immune cells. This complex is essential for recognizing lipopolysaccharides (LPS), which are molecules found on the outer membranes of certain bacteria. By detecting these microbial signals, the MD-2/TLR4 complex triggers inflammatory pathways that help the body defend against infection. Beyond its role in bacterial defense, MD-2 has been studied for its potential involvement in allergic inflammation. Because the house dust mite allergen Der p 2 shares structural similarities with MD-2, some researchers have explored whether variations in the MD-2 promoter might influence how the immune system responds to these specific environmental allergens, potentially modulating the production of IgE antibodies.
Research and Evidence Strength
The evidence linking rs1809441 to allergic traits is currently considered limited and context-dependent. Some studies, particularly those involving specific cohorts in Taiwan, have reported that individuals carrying certain genotypes at this locus showed higher levels of Der p 2-specific IgE and a higher prevalence of allergic symptoms like asthma or skin reactions. These researchers suggested that the variant might lead to increased MD-2 expression, which could theoretically enhance inflammatory responses to allergens. However, other studies have not found consistent associations; for example, research investigating the same promoter variants in relation to tuberculosis susceptibility in different populations found no significant differences between patients and healthy controls. Because these findings are often specific to certain populations and environmental exposures, the scientific community views the evidence as preliminary. It is not currently used as a diagnostic tool, and more large-scale, diverse studies are required to confirm the clinical relevance of this variant.
Population Frequency
According to data from the 1000 Genomes Project, the minor allele frequency for rs1809441 is approximately 0.467. This indicates that the variant is relatively common across the populations studied in that project. Because it is a common variant, it is found in a significant portion of the general population, which is why it is frequently included in genetic association studies. However, allele frequencies can vary significantly between different ancestral groups, and the prevalence of specific genotypes may differ based on geographic and ethnic background. Understanding these frequencies is important for researchers to ensure that genetic studies are representative and to avoid drawing conclusions that may not apply to all human populations.
What This Information Means for You
If you have encountered information about your rs1809441 genotype, it is important to interpret it with caution. Genetic associations, especially those related to complex traits like allergies, are statistical observations made across groups of people and do not provide a direct prediction of an individual's health. Many factors, including your environment, lifestyle, and the complex interplay of thousands of other genes, contribute to your immune system's function. This variant is not a diagnostic marker for any condition, and having a specific genotype does not mean you will develop an allergy or that you are protected from one. If you have concerns about allergies or your immune health, the most effective approach is to consult with a qualified healthcare provider or an allergist. They can perform clinical tests to assess your actual health status and provide personalized advice, which is far more reliable than relying on individual genetic markers.
How common is this variant?
The minor allele frequency for rs1809441 is 0.467 based on 1000 Genomes Project data, indicating it is a common variant across diverse populations.
Frequently asked questions
Is rs1809441 a diagnostic test for allergies?
No, rs1809441 is not a diagnostic test. It is a genetic variant that has been studied for statistical associations with allergic traits, but it cannot predict whether an individual will develop an allergy.
Should I change my medication based on my rs1809441 genotype?
No. You should never change your medication based on genetic information without consulting your doctor or pharmacist. Always discuss your treatment plan with a qualified healthcare professional.
What does it mean if I have the TT genotype?
The TT genotype is simply one of the possible genetic configurations at this location. While some research has explored its association with allergic markers, it does not mean you have a disease or a specific health condition.
Are these findings applicable to everyone?
Not necessarily. Genetic associations are often specific to the populations studied. Findings from one group may not be replicated in other populations with different genetic backgrounds or environmental exposures.
Sources & further reading
Educational information only, last refreshed 10/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1809441?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29